The in vivo anti-tumor activity of dual treatment on T - cell lymphoma was further evaluated in
a murine xenograft model in which KMT2D V5486M mutated Jurkat cells subcutaneously injected into nude mice.
Not exact matches
(C) In vivo effect of the CHID and DECI combination in a
murine T - lymphoma
xenograft model.
(G) Immunostaining of p - ERK in tumor samples of
xenografted murine models bearing KMT2D V5486 mutants treated with CHID and / or DECI.